TTNP | Titan Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.57 - 3.95
52 Week Range	3.51 - 14.80
Beta	0.80
Implied Volatility	526.27%
IV Rank	N/A
Day's Volume	14,957
Average Volume	40,734
Shares Outstanding	914,234
Market Cap	3,336,954
Sector	Healthcare
Industry	Biotechnology
IPO Date	1996-01-18

Valuation
Profitability
Growth
Health
P/E Ratio	-0.55
Forward P/E Ratio	N/A
EPS	-6.64
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	TTNP

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

TTNP's peers: FWBI, SLRX, SABS, VCNX, GOVX, SNTI, ZIVO, CVKD, FHTX, QNRX, CMRA, PCSA, FRTX, THRD, NRBO, INDP, KTTA, LIXT

*Chart delayed

Analyzing fundamentals for TTNP we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see TTNP Fundamentals page.

Watching at TTNP technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on TTNP Technicals page.